MIT News | Massachusetts Institute of Technology

MIT researchers have developed a method to grow artificial muscle tissue that twitches and flexes in multiple, coordinated directions, and could be useful for building “biohybrid” robots, reports Andrew Corselli for Tech Briefs. Prof. Ritu Raman explains that her lab is focused on creating “artificial muscle tissues that can be used to understand and treat muscle diseases that impact healthy human mobility,” and making “safe muscle-powered robots that can perform complex tasks in dangerous environments that are not suitable for humans.”

Graduate student Cathy Fang speaks with CBS News reporter Lindsey Reiser about her research studying the effects of AI chatbots on people’s emotional well-being. Fang explains that she and her colleagues found that how the chatbot interacts with the user is important, “but also how the user interacts with the chatbot is equally important. Both influence the user’s emotional and social well-being.” She adds: “Overall, we found that extended use is correlated with more negative outcomes.”

Biogen will move its headquarters to MIT’s Kendall Common development in 2028, reports Catherine Carlock and Jonathan Saltzman for The Boston Globe. “Biogen has been a foundational presence in the Massachusetts life science ecosystem for close to half a century,” says Governor Maura Healey. “We are thrilled to see them begin a new era in our state.”

Sloan Lecturer Harvey Michaels speaks with Boston Globe reporter Scooty Nickerson about skyrocketing energy costs in Massachusetts. Michaels explains that one contributing factor is the vast but costly energy system that can supply heat during cold dips but is expensive to maintain. “It’s like having a fleet of planes flying around with very few passengers on them,” Michaels explains. “It’s going to be very expensive for the passengers that do fly” to make it worth it.

MIT researchers have developed a “simple way to administer long-acting drug delivery systems without the need for invasive procedures – an appealing prospect for parts of the world with poor medical infrastructure,” reports Nicola Davis for The Guardian. “It’s suitable for any poorly soluble hydrophobic drug, especially where long-acting delivery is needed,” says Prof. Giovanni Traverso, “This includes treatments for HIV, TB, schizophrenia, chronic pain, or metabolic disease​.” 

Researchers at MIT and elsewhere have found “that frequency chatbot users experience more loneliness and emotional dependence,” reports Beatrice Nolan for Fortune. “The studies set out to investigate the extent to which interactions with ChatGPT impacted users’ emotional health, with a focus on the use of the chatbot’s advanced voice mode,” explains Nolan. 

CNBC reporter Kif Leswing spotlights Lisa Su '90, SM '91, PhD '94 and her work as CEO of Advanced Micro Devices (AMD). “On Su’s watch, AMD was the first major company to embrace a technology called ‘chiplets,’” writes Leswing. “Instead of manufacturing one big chip with all the elements needed — the compute cores as well as an input and output block — AMD could make smaller chips and then assemble them together.” 

Prof. David Schmittlein, the longest serving dean of the MIT Sloan School of Management who was known for his role expanding Sloan’s international reach, has died at the age of 69, reports Bryan Marquard for The Boston Globe. Schmittlein “led initiatives introducing several new degree programs, redesigning the academic program portfolio while maintaining the MBA as the flagship degree, and diversifying executive offerings,” writes Marquard. 

Prof. Jonathan Gruber speaks with Marketplace reporter Elizabeth Trovall about looming labor shortages within the caregiving industry and elder care. “We have no plan for credibly meeting that massive change in the long-term care needs of our population,” says Gruber.